Darinaparsin: a novel organic arsenical with promising anticancer activity

Chemical and Clinical Development of Darinaparsin, a Novel Organic Arsenic Derivative

(2012) Alfonso Quintas-Cardama et al.   Anti-Cancer Agents in Medicinal Chemistry

Darinaparsin induces a unique cellular response and is active in an arsenic trioxide-resistant myeloma cell line

(2009) S. M. Matulis et al.   MOLECULAR CANCER THERAPEUTICS

Management of acute promyelocytic leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet

(2008) M. A. Sanz et al.   BLOOD

Monomethylarsonous Acid Destroys a Tetrathiolate Zinc Finger Much More Efficiently than Inorganic Arsenite: Mechanistic Considerations and Consequences for DNA Repair Inhibition

(2008) Katarzyna Pia̧tek et al.   CHEMICAL RESEARCH IN TOXICOLOGY

A novel arsenical has antitumor activity toward As2O3-resistant and MRP1/ABCC1-overexpressing cell lines

(2008) Z Diaz et al.   LEUKEMIA

The Expanding Role of Arsenic in Acute Promyelocytic Leukemia

(2008) Martin S. Tallman   SEMINARS IN HEMATOLOGY

Toxicity of inorganic arsenic and its metabolites on haematopoietic progenitors “in vitro”: Comparison between species and sexes

(2008) Daniele Ferrario et al.   TOXICOLOGY